Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01899040 · ClinicalTrials.gov registry record · NA
A Non-Invasive Neuromodulation Device for Treatment of Migraine Headache
A NA study, sponsored by Scion NeuroStim.
- Completed
- Registry status
- NA
- Development phase
- 100
- Enrollment target
NCT01899040 is a NA study that has completed, run by Scion NeuroStim. The registered enrollment target is 100 participants.
The verdict
NCT01899040, a NA study, has completed, sponsored by Scion NeuroStim.
- COMPLETED
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
Study Summary
This is a randomized, blinded study designed to assess the efficacy of a portable, non-invasive neuromodulation system for the treatment of episodic migraine headaches.
Interventions
- DEVICE neuromodulation for episodic migraine headache
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2013-08 |
| Est. Completion | 2016-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01899040
The ClinicalTrials.gov registry entry for NCT01899040 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Scion NeuroStim, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which neuromodulation for episodic migraine headache is the first listed.
NCT01899040 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01899040 about?
NCT01899040 is a clinical study titled "A Non-Invasive Neuromodulation Device for Treatment of Migraine Headache". This is a randomized, blinded study designed to assess the efficacy of a portable, non-invasive neuromodulation system for the treatment of episodic migraine headaches.
What is the current status of trial NCT01899040?
This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2013-08. Estimated completion is 2016-06.
What interventions are being tested in trial NCT01899040?
The interventions under investigation include: neuromodulation for episodic migraine headache (DEVICE).
Who is sponsoring clinical trial NCT01899040?
This trial is sponsored by Scion NeuroStim, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.